Possible scenario
Partnerships Follow Launch
22% Chance
The competition becomes a business-development funnel for Prima Mente. Pharmaceutical companies, AI drug-discovery firms, and cloud providers use the challenge to evaluate access to the atlas and related modeling infrastructure.
Secondary impacts
- Healthcare +0.4%
- Technology +0.3%
Tickers
- LLY+0.4%
- RXRX+0.2%
- SDGR+0.2%
- AMZN+0.1%
- +0.1%
Portfolio impact
S&P 500+0.2%
Each figure is the modeled move of the S&P 500 if the outcome occurs. For information only. Not investment advice.
Keeping an eye on this scenario?
Tilt can alert you when its probability or impact shifts, or send you a recommendation when it crosses a threshold.